Dynamics of Viral Variants in HIV-1 Nef and Specific Cytotoxic T Lymphocytes in Vivo

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4212-4221

  Haas, Gaby ^a   Plikat, Uwe ^b   Debré, Patrice ^a   Lucchiari, Maria ^c   Katlama, Christine ^a   Dudoit, Yasmine ^a   Bonduelle, Olivia ^a   Bauer, Monika ^b   Ihlenfeldt, Hans Georg ^d   Jung, Günther ^d   Maier, Bernhard ^c   Meyerhans, Andreas ^b   Autran, Brigitte ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A ANTIGEN; NEF PROTEIN; VIRUS DNA;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; ARTICLE; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE COURSE; FOLLOW UP; GENETIC SELECTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; PROVIRUS; REGULATOR GENE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; DNA, VIRAL; EPITOPES; FOLLOW-UP STUDIES; GENE PRODUCTS, NEF; GENES, NEF; HIV-1; HLA-A ANTIGENS; HUMANS; PROVIRUSES; SELECTION (GENETICS); SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030293534     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Plata, F., B. Autran, L. P. Martins, S. Wain-Hobson, M. Raphael, C. Mayaud, M. Denis, J. M. Guillon, and P. Debré. 1987. AIDS-virus specific cytotoxic T-lymphocytes in lung disorders. Nature 328:348.
2. Walker, B. D., C. Flexner, T. J. Paradis, T. C. Fuller, M. S. Hirsch, R. T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64.
3. Chenciner, N., F. Michel, G. Dadaglio, P. Langlade-Demoyen, A. Hoffenbach, A. Leroux, F. Garcia-Pons, G. Rautmann, B. Guy, J. M. Guillon, C. Mayaud, M. Girard, B. Autran, M. P. Kieny, and F. Plata. 1989. Multiple subsets of HIV-specific cytotoxic T lymphocytes in mice and human. Eur. J. Immunol. 337:743.
4. Riviere, Y., F. Tanneau-Salvadori, A. Regnault, O. Lopez, P. Sansonetti, B. Guy, M. P. Kieny, J. J. Fournel, and L. Montagnier. 1989. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing Gag and Env proteins. J. Virol. 63:2270.
5. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. J. Immunol. 147:1512.
6. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175(4):961.
7. Koup, R. A., J. T. Safrit, Y. Cao, A. Andrews, W. Mcleod-Borkosky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.
8. Byrne, J. A., and M. B. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682.
9. + T cells and nonspecific bone marrow-derived cells. J. Virol. 61:3930.
10. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma varions and CD4 lymphocytes in HIV-1 infection. Nature 373:123.
11. Wei, W., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117.
12. Phillips, R. E., S. Rowland-Jones, D. Nixon, F. M. Gotch, P. Edwards. A. Ogulensi, J. G. Elvin, J. A. Rothbard, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. Nature 354:453.
13. Couillin, I., F. Connan, B. Culmann-Penciolelli, E. Gomard, J. G. Guillet, and J. Choppin. 1995. HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding. Eur. J. Immunol. 25:728.
14. McAdam, S., P. Klenermann, L. Tussey, S. Rowland-Jones, D. Lalloo, R. Philipps, A. Edwards, P. Giangrande, A. Leigh Brown, F. Gotch, and A. McMichael. 1995. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J. Immunol. 155:2729.
15. + T cells. Eur. J. Immunol. 23:3306.
16. Meyerhans, A., G. Dadaglio, J. P. Vartanian, P. Langlade-Demoyen, R. Frank, B. Asjö, F. Plata, and S. Wain-Hobson. 1991. In vivo persistence of an HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur. J. Immunol. 21:2637.
17. Chen, Z. W., L. Shen, M. D. Miller, S. H. Ghim, A. L. Hughes, and N. L. Letvin. 1992. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J. Immunol. 149: 4060.
18. Pelletier, E., W. Saurin, R. Cheynier, N. L. Letvin, and S. Wain-Hobson. 1995. The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology 208:644,
19. Wain-Hobson, S. 1992. Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr. Top. Microbiol. Immunol. 176:181.
20. De Magistris, M. T., J. Alexander, M. Coggeshall, A. Altman, F. Gaeta, H. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625.
21. Bertoletti, A., A. Sette, F. Chisari, A. Penna, M. Levrero, M. Decarli, F. Fiaccadori, and C. Ferran. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407.
22. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenk, D. Lailoo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.
23. Meier, U. C., P. Klenerman, P. Griffin, W. James, B. Koppe, B. Larder, A. McMichael, and R. Phillips. 1995. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 270:1360.
24. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606.
25. Wolinsky, S. M., B. T. M. Korbet, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Do, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 272:537.
26. Delwart, E. L., W. Haynes, W. Sheppard, B. D. Walker, J. Goudsmit, and J. I. Mullins. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heleroduplex mobility assays. J Virol. 68:6672.
27. Hadida, F., A. Parrot, M. P. Kieny, B. Sadat-Sowti, P. Debré, and B. Autran. 1992. Carboxyl-terminal and central regions of HIV-1 Nef recognized by cytotoxic T lymphocytes from lymphoid organs. J. Clin. Invest. 89:53.
28. Culmann, B., E. Gomard, M. P. Kieny, B. Guy, F. Dreyfus, H. Adrien-Gerard, G. Saimot, D. Sereni, and J. P. Levy. 1989. An antigenic peptide of the HIV-1 Nef protein recognized by cy totoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur. J. Immunol. 12:2383.
29. Nixon, D. F., A. R. M. Townsend, J. G. Elvin, C. R. Rizza, J. Gallwey, and A. J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484.
30. Hadida, F., G. Haas, N. Zimmermann, A. Hosmalin, A. Samri, R. Spohri, R. Jung, P. Debré, and B. Autran. 1995. Cytotoxic T lymphocytes from lymphoid organs recognize an optimal HLA-A2 and -B52 restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. J. Immunol. 154:4174.
31. Salter, R. D., C. Clayberger, C. E. Lomen, A. M. Krensky, and P. Parham. 1982. In vitro mutagenesis at a single residue, introduces B and T cell epitopes into a class I HLA molecule. Eur. J. Immunol. 166:283.
32. Lucchiari, M., G. Niedermann, C. Leipner, A. Meyerhans, K. Eichmann, and B. Maier. 1994. Human immune response to HIV-1 Nef. I. CD45RO-T lymphocytes of non infected donors contain CTL-precursors at high frequency. Int. Immunol. 6:1939.
33. Rinaldo, C., X. L. X. L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of antihuman immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term non-progressors. J. Virol. 69:5838.
34. Jung, G., and A. G. Beck-Sickinger. 1992. Multiple peptide synthesis methods and their application. Angew. Chem. Int. Ed. Engl. 31:367.
35. Maier, R., K. Falk, O. Rötzschke, B. Maier, V. Gnau, S. Stevanovié, G. Jung, H. G. Rammensee, and A. Meyerhans. 1994. Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing, Immunogenetics 40:306.
36. Fetten, J., N. Roy, and E. Gilboa. 1991. Frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. J. Immunol. 147:2697.
37. Myers, G., S. Wain-Hobson, B. Korber, and R. F. Smith. 1993. Human Retro-viruses and AIDS. Los Alamos National Laboratory, Los Alamos, NM.
38. Huang, Y., L. Zhang, and D. Ho. 1995. Characterization of Nef sequences in longterm survivors of human immunodeficiency virus type 1 infection. J. Virol. 69:8142.
39. Baur, A. S., E. T. Sawai, P. Dazin, W. J. Fanti, C. Cheng-Mayer, and B. M. Peterlin. 1994. HIV-1 Nef leads to inhibition of activation of T cells depending on its intracellular localization. Immunity 1:373.
40. Sawai, E. T., A. Baur, H. Struble, B. M. Peterlin, J. A. Levy, and C. Cheng-Mayer. 1994. Human immunodeficiency virus type 1 nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA 91: 1539.
41. + viruses but not for down-regulation of CD4. EMBO J. 14:484.
42. Del Val, M., H. J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145.
43. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
44. Shearer, G. M., and M. Clerici. 1991. Early T helper cell deficits in HIV infection. AIDS 5:245.
45. De Groot, A. S., M. Clerici, A. Hosmalin, S. H. Hugues, D. Barnd, C. W. Hendrix, R. Houghten, G. M. Shearer, and I. A. Berzofsky 1991. HIV reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope. J. Infect. Dis. 164:1058.
46. Alexander-Miller, M., K. Parker, C. Tsukui, C. Pendlelon, J. Coligan, and A. Berzofsky. 1995. P18-specific, HLA-A2 restricted and H-2Dd restricted CTL share a common minimal epitope which utilizes similar residues for MHC. J. Cell. Biochem. 21A(Suppl.):135 (Abstr.).
47. Nahill, S. R., and R. M. Welsh. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177:317.
48. Cheynier, R., S. Henrichwark, F. Hadida, E. Pelletier, E. Oksenhendler, B. Autran, and S. Wain-Hobson. 1994. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78:373.
49. + T cells. Science 270:1811.
50. Joly, P., J. M. Guillon, C. Mayaud, F. Plata, M. Denis, I. Theodorou, P. Debré, and B. Autran. 1989, Cell-mediated suppression of HIV-specific cytotoxic effector cells. J. Immunol. 143:2193.
51. Hoffenbach, A., P. Langlade-Demoyen, E. Vilmer, G. Dadaglio, F. Michel, C. Mayaud, B. Autran, and F. Plata. 1989. Very high frequencies of HIV specific cytotoxic T lymphocytes in humans. J. Immunol. 142:452.
52. Klein M. R., C. A. vanBaalen., A. M. Holwerda., K. S. R Garde, R. J. BendeKeet, I. P. M. Eeftinck-Schattenkerk, A. D. M. E Osterhaus, H. Schuitemaker, F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
53. Moss, P. A. H., S. L. Rowland-Jones, P. M. Frodsham, S. McAdam, P. Giangrande, A. J. McMichael, and J. I. Bell. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donnors. Proc. Natl. Acad. Sci. USA 92:5773.